2017 Seminar Series
December 1st: Heshan Peiris (Kim lab - Conditional Genetics and Human Islet Studies to Discover Diabetes Risk Gene Function)/Krissie Tellez (Kim lab - Elucidating in Vivo Mechanisms Regulating Glucagon Secretion in a Glucagon Null Mouse)
November 3rd: Tim Horton (Annes lab -Zinc chelators as beta-cell selective agents)/Kent Jensen (introduction to SIRC and DIMC cores)
October 6th: Knowles Lab (Heritable Diabetes and Metabolic Risk)/ Snyder Lab (Diabetes Omics)
September 1: Kay Lab (Islet Targeting)/ Meyer Lab (Immune cell targeting of the Islet)
July 7: Bollyky Lab (Type I diabetes Protection)/ McLaughlin Lab (CD44 and T2D)
June 2: Feldman Lab
Brian J. Feldman (Feldman lab): "Hypertrophy or hyperplasia: post-prandial contemplations."
Avnesh S. Thakor (Thakor Lab): "Delivery of therapeutics directly to the pancreas."
May 5th, 2017
Heshan Peiris (Seung Kim Lab): BCL11A: A T2D Risk Gene From GWAS That Regulates Human Beta Cell Function
Hannah Moeller (Justin Annes Lab): Discovering mechanisms for promoting the beta cell identity
April 26th 2017, 9AM-5PM
Frontiers in Diabetes Research at Stanford